Clinical Trial Update: Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a Stroke [Phase 2]

View source ↗

Summary

A Phase 2 proof-of-concept study evaluating alfimeprase to rapidly open brain arteries after acute ischemic stroke was terminated before completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Alfimeprase (alfimeprase)

Snippet

Sponsor: ARCA Biopharma, Inc. | Conditions: Acute Ischemic Stroke | Phase 2 | Status: TERMINATED